NASDAQ:XAGE Longevity Health (XAGE) Stock Price, News & Analysis $2.83 -0.09 (-3.08%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About Longevity Health Stock (NASDAQ:XAGE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Longevity Health alerts:Sign Up Key Stats Today's Range$2.75▼$2.9250-Day Range N/A52-Week Range$2.20▼$38.10Volume13,907 shsAverage Volume5.53 million shsMarket Capitalization$2.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania. Read More Receive XAGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Longevity Health and its competitors with MarketBeat's FREE daily newsletter. Email Address XAGE Stock News HeadlinesReShape Lifesciences (OTCMKTS:RSLSD) versus Longevity Health (NASDAQ:XAGE) Head-To-Head ComparisonAugust 1 at 3:49 AM | americanbankingnews.comLongevity Health (NASDAQ:XAGE) vs. ReShape Lifesciences (OTCMKTS:RSLSD) Head-To-Head ContrastJuly 31 at 3:05 AM | americanbankingnews.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.August 2 at 2:00 AM | Porter & Company (Ad)Contrasting Longevity Health (NASDAQ:XAGE) & TransEnterix (OTCMKTS:TRXDW)July 25, 2025 | americanbankingnews.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comLongevity Health Holdings, Inc.: Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs TransactionJuly 15, 2025 | finanznachrichten.deLongevity Health Holdings to Merge With True HealthJuly 15, 2025 | marketwatch.comSee More Headlines XAGE Stock Analysis - Frequently Asked Questions How have XAGE shares performed this year? Longevity Health's stock was trading at $2.59 on January 1st, 2025. Since then, XAGE shares have increased by 9.3% and is now trading at $2.83. How do I buy shares of Longevity Health? Shares of XAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today8/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical, Medical, And Dental Instruments And Supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:XAGE CIK1842939 WebN/A Phone(412) 894-8248FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.37 million Net Margins-1,535.11% Pretax Margin-1,552.42% Return on EquityN/A Return on Assets-280.07% Debt Debt-to-Equity RatioN/A Current Ratio0.42 Quick Ratio0.21 Sales & Book Value Annual Sales$50 thousand Price / Sales56.60 Cash FlowN/A Price / Cash FlowN/A Book Value($6.77) per share Price / Book-0.42Miscellaneous Outstanding Shares1,000,000Free Float713,000Market Cap$2.83 million OptionableN/A Beta0.51 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:XAGE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
